PTK2 and neoplasm: FAK (Y397) activation not only induces the depletion of CD8+T cells in tumor microenvironment (TME) but also promotes tumor cells to secrete chemokines/cytokines, recruiting Treg cells and inhibiting the activity of effector CD8+T cells [14].